Pluto Biosciences, Inc

GSE123740: SUM52PE treated with PI3K-mTOR inhibitors

Bulk RNA sequencing

PI3K/mTOR inhibition alters gene transcription signatures involved in metabolism and cell cycle control in the human breast cancer cell line, SUM52PE SOURCE: Pilar Blancafort (pilar.blancafort@uwa.edu.au) - Cancer Epigenetics Harry Perkins Institute of Medical Research

View this experiment on Pluto Biosciences, Inc